The use of recombinant factor VIIa in a patient with essential thrombocythaemia with uncontrolled surgical bleeding

Armando V. Mena-Durán, Cristina Sanchís Piqueras, José Sanchís Cervera

Thrombosis and Haemostasis · 2005 · 11 citations · 9 references

Concepts

Abstract

Essential thrombocythaemia is a chronic myeloproliferative disorder characterized by excessive proliferation of megakaryocytes with sustained increase of platelets count. Thromboembolic complications are major causes of morbidity and mortality. Severe bleeding is less frequent, and is usually seen in patients with very a high platelet count. The cause of bleeding seems to be an acquired platelet dysfunction. Activated recombinant FVII (rFVIIa) has shown to be haemostatically effective in bleeding associated with thrombocytopathy (6–8). Here we report a case, which suggests that rFVIIa might be a therapeutic option for uncontrolled bleeding in patients with essential thrombocythaemia. . . .

References

9